HHS has denied any nefarious intent behind the FDA’s removal of the page. In a statement to Ars Technica, a representative ...

CHELATION THERAPY HAS been around for decades as a treatment for toxic metal poisoning. But, there have also been claims that the therapy could help several other conditions. Experts aren't so sure.

But, under anti-vaccine Health Secretary Robert F. Kennedy Jr.—who has numerous ties to the wellness industry—that FDA information webpage is now gone. It was quietly deleted at the end of last year, ...

MIAMI BEACH, Fla. — The new heart patient asked Dr. Gervasio Lamas if he thought chelation therapy was worth a try. “Of course not!” the cardiologist replied emphatically. His Harvard training had ...

(NIMH) says its investigators would not go forward with a trial of chelation (pronounced kee-LAY-shun) therapy that has been discussed for the past two years. The decision was made after the federal ...

Overall, those receiving chelation had an 18% reduced risk of subsequent cardiovascular events, such as heart attack, stroke, hospitalization for angina, or coronary revascularization or death from ...

HOLLYWOOD, FL—Patients with critical limb ischemia (CLI) on the backdrop of diabetes may get some relief from their leg and foot symptoms if toxic metals are removed from their body via chelation, ...

For someone who has diabetes, and has also already suffered a heart problem, the chances for another heart attack, stroke or sudden death are very high. The government has now funded a new clinical ...

When determining the types of patients to be recruited for the trial, there was concern that the benefits of chelation might not be easily discerned if the participants were too healthy; patients who ...

NEW YORK (Reuters Health) - Removing heavy metals from the body through a process traditionally used to treat mercury and lead poisoning doesn't help relieve autism symptoms, a new analysis suggests.

ATLANTA, GA—More than a decade after the TACT trial reported an astonishing reduction in cardiovascular events post-MI with heavy metal chelation in a subset of diabetic patients, the TACT2 trial, ...